National Taiwan University Hospital ( Site 4000)

Taipei 10002

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Esophageal Squamous Cell Carcinoma, Neoplasms, Pancreatic Neoplasms

Studies at this site

• A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B) — Recruiting now
• A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) — Stopped early